Heart Rate Beat-to-Beat Slope Change during Six-Minute Walk Test: a Useful Clinical Tool for Estimating Fitness level

##plugins.themes.academic_pro.article.sidebar##

Published Sep 22, 2017
Download
pdf
Vol. 94 No. 12 (2016): Issue Dec 2016

##plugins.themes.academic_pro.article.main##

Abdulrahman Mohammed Alhowikan
Abdullah A. Alfaifi
Badr A. Almutairi
Omar A. Alzamil
Muath A. Aleid

Abstract

Background: The six-minute walk test (6MWT) is one of the most common exercise tests and is used to estimate the level of physical fitness. This study aimed to evaluate the feasibility of the beat-to-beat heart rate 6MWT slope (6MWTS) and recovery slope for predicting and estimating the level of physical fitness during 6MWT, instead of depending on the distance covered during the test.

Methods: Seventy healthy adult male subjects aged 18 to 27 years were recruited randomly from the general Saudi population in Riyadh. Using a 50-m corridor, 6MWT was performed according to standardised American Thoracic Society guidelines.

Results: The mean distance walked in 6 minutes (470.5±64.6 m) and beat-to-beat heart rate (HR) were calculated using a HR monitor. In addition, the body mass index, body surface area, Borg Rating of Perceived Exertion, and maximum predicted HR percentage were also calculated. A stepwise regression equation was used to predict the 6MWT distance (6MWTD), 6MWTS, and recovery slope. There was a significant correlation between 6MWTS and the recovery slope (r= -0.575, p<0.001), between 6MWTS and 6MWTD (r= 0.414, p<0.001), and between recovery slope and 6MWTD (r= -0.454, p<0.001).

Conclusion: Our findings suggest that both 6MWTS and recovery slope can predict 6MWTD.

Keywords:

Heart rate, six-minute walk test, beat-to-beat heart rate slope, physical fitness, covered distance

##plugins.themes.academic_pro.article.details##

References

  1. Blair SN, Horton E, Leon AS, et al. Physical activity, nutrition, and chronic disease. Med Sci Sports 1996;28(3):335-49.
  2. Briffa TG, Maiorana A, Sheerin NJ, et al. Physical activity for people with cardiovascular disease: recommendations of the National Heart Foundation of Australia. Med J Aust 2006;184(2):71.
  3. Jehn M, Schmidt-Trucksäess A, Schuster T, et al. Accelerometer-based quantification of 6-minute walk test performance in patients with chronic heart failure: applicability in telemedicine. J Card Fail 2009;15(4):334-40
  4. Laboratories ACoPSfCPF. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111.
  5. Rasekaba T, Lee A, Naughton M, Williams T, Holland A. The sixâ€minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J 2009;39(8):495-501.
  6. Brown CD, Wise RA. Field tests of exercise in COPD: the six-minute walk test and the shuttle walk test. COPD 2007;4(3):217-23.
  7. Ulrich S, Hildenbrand FF, Treder U, et al. Reference values for the 6-minute walk test in healthy children and adolescents in Switzerland. BMC Pulm Med 2013;13(1):49.
  8. Lipkin D, Scriven A, Crake T, Poole-Wilson P. Six minute walking test for assessing exercise capacity in chronic heart failure. BMJ 1986;292(6521):653.
  9. O'Keeffe S, Lye M, Donnellan C, Carmichael D. Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients. Heart 1998;80(4):377-82
  10. Chetta A, Pisi G, Aiello M, Tzani P, Olivieri D. The walking capacity assessment in the respiratory patient. Respiration 2009;77(4):361-7.
  11. Du H, Newton PJ, Salamonson Y, Carrieri-Kohlman VL, Davidson PM. A review of the six-minute walk test: its implication as a self-administered assessment tool. Eur J Cardiovasc Nurs 2009;8(1):2-8.
  12. Humbert M, Sitbon O, Yaici A, et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 2010;36(3):549-55.
  13. Benza RL, Gomberg-Maitland M, Miller DP, et al. The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension. Chest 2012;141(2):354-62.
  14. Simonneau G, Rubin LJ, Galie N, et al. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial. Ann Intern Med 2008;149(8):521-30.
  15. Galiè N, Brundage B, Ghofrani H, et al. Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group. Tadalafil therapy for pulmonary arterial hypertension. Circulation 2009;119(22):2894-903.
  16. McLaughlin VV, Benza RL, Rubin LJ, et al. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. JACC 2010;55(18):1915-22.
  17. Tonelli AR, Wang XF, Alkukhun L, Zhang Q, Dweik RA, Minai OA. Heart rate slopes during 6â€min walk test in pulmonary arterial hypertension, other lung diseases, and healthy controls. Physiol Rep 2014;2(6):e12038.
  18. Chisholm D, Collis M, Kulak L, Davenport W, Gruber N. Physical activity readiness. B C Med J 1975;17(2):375-8.
  19. Mosteller R. Simplified calculation of body-surface area. N Engl J Med 1987;317(17):1098.
  20. Alameri H, Al-Majed S, Al-Howaikan A. Six-min walk test in a healthy adult Arab population. Respir Med 2009;103(7):1041-6.
  21. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J 1999;14(2):270-4.
  22. Enright PL. The six-minute walk test. Respir Care. 2003;48(8):783-5.
  23. Casillas J-M, Hannequin A, Besson D, et al. Walking tests during the exercise training: Specific use for the cardiac rehabilitation. Annals of physical and rehabilitation medicine. 2013;56(7):561-75.
  24. Li A, Yin J, Yu C, et al. The six-minute walk test in healthy children: reliability and validity. European Respiratory Journal. 2005;25(6):1057-60.
  25. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998;158(5):1384-7.
  26. Burr JF, Bredin SS, Faktor MD, Warburton DE. The 6-minute walk test as a predictor of objectively measured aerobic fitness in healthy working-aged adults. Phys Sportsmed 2011;39(2):133-9.